GlassScriptPhysician profile
Ezra Teitelbaum
NPI 1104052521
$85,079.75
in general payments reported to CMS, 2019-2025
6 companies · $12K in 2025
The $12K reported for 2025 was more than what 95% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $26K · 2021: $8,360 · 2022: $4,985 · 2023: $15K · 2024: $6,943 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24K · Consulting Fee: $6,500 · Travel and Lodging: $2,001 · Food and Beverage: $822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24,125.00 |
| Consulting Fee | $6,500.00 |
| Travel and Lodging | $2,001.45 |
| Food and Beverage | $821.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $81,870.59 | 2019-2025 | Spyglass Discover, Spyglass, Exalt Model D |
| Cook Medical LLC | $1,747.09 | 2019 | |
| Medical Device Business Services, INC. | $949.96 | 2020 | |
| Intuitive Surgical, INC. | $320.53 | 2019-2025 | |
| W. L. Gore & Associates, INC. | $158.64 | 2025 | Gore Enform Preperitoneal Biomaterial |
| Cook Incorporated | $32.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ezra Teitelbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.